Science

It is equally fair to say that lung cancer treatment has come a long way, and that it has a long way to go. Speaking at a joint conference by the International Association for the Study of Lung Cancer and the American Association for Cancer Research on lung cancer translational research, William Pao remembered the stark realities of being an oncology fellow at Memorial Sloan-Kettering Cancer Center just 20 years ago, when the main lung cancer “procedure” done by trainees was to get a DNR, or do-not-resuscitate order, from their patients.

BioWorld MedTech’s Oncology Extra for Jan. 14, 2020

January 14, 2020

By Mark McCarty and Anette Breindl

No Comments

Keeping you up to date on recent developments in oncology.

Slicing the pie chart

As KRAS inhibitors proceed, subtypes take on clinical importance

January 14, 2020

By Anette Breindl

No Comments

SAN DIEGO – Allele-specific KRAS inhibitors are “the most exciting change coming down the pike for treating KRAS-mutant tumors in the near future,” Ferdinandos Skoulidis said at the sixth joint conference by the American Association for Cancer Research and the International Association for the Study of Lung Cancer meeting.

BioWorld MedTech’s Cardiology Extra for Jan. 13, 2020

January 13, 2020

By Liz Hollis

No Comments

Keeping you up to date on recent developments in cardiology.

Bench Press for Jan. 10, 2020

January 10, 2020

By Anette Breindl

No Comments

A University of California, San Diego-led team from the Alzheimer’s Disease Neuroimaging Initiative has reported that in long-term imaging studies, objective subtle cognitive deficits (obj-SCD) preceded amyloid deposition in longitudinal imaging studies.

BioWorld MedTech’s Neurology Extra for Jan. 10, 2020

January 10, 2020

By Andrea Applegate

No Comments

Keeping you up to date on recent developments in neurology.

The unknown unknowns

New brain-controlled, bodywide anti-aging mechanism identified

January 10, 2020

By Anette Breindl

No Comments

How organisms age, and what determines their lifespan, is one of the basic questions of biology. It is also a major area of biopharmaceutical interest. Partly, this is because most people want to delay shuffling off this mortal coil for as long as possible.